Viral target- and metabolism-based rationale for combined use of recently authorized small molecule COVID-19 medicines: molnupiravir, nirmatrelvir and remdesivirArticle Published on 2023-04-102024-09-05 Journal: Fundamental & clinical pharmacology [Category] update2024, [키워드] main protease molnupiravir Nirmatrelvir Remdesivir RNA-dependent RNA-polymerase SARS-CoV-2 [DOI] 10.1111/fcp.12889 PMC 바로가기 [Article Type] Article
Coronavirus Disease 2019 Management Strategies in Solid Organ Transplant RecipientsArticle Published on 2023-03-212024-09-05 Journal: Infectious disease clinics of North America [Category] update2024, [키워드] anti-spike monoclonal antibodies coronavirus disease-2019 COVID-19 molnupiravir Nirmatrelvir Remdesivir transplantation [DOI] 10.1016/j.idc.2023.03.003 PMC 바로가기 [Article Type] Article
Potential RNA-dependent RNA polymerase (RdRp) inhibitors as prospective drug candidates for SARS-CoV-2Review Article Published on 2023-03-182024-09-05 Journal: European journal of medicinal chemistry [Category] update2024, [키워드] computational studies COVID-19 Favipiravir molnupiravir polymerase RdRP Remdesivir SARS-CoV-2 [DOI] 10.1016/j.ejmech.2023.115292 PMC 바로가기 [Article Type] Review Article
Potential anti-mpox virus activity of atovaquone, mefloquine, and molnupiravir, and their potential use as treatmentsArticle Published on 2023-03-092023-06-10 Journal: The Journal of Infectious Diseases [Category] 원숭이두창, [키워드] Antiviral atovaquone dihydroorotate dehydrogenase mefloquine molnupiravir mpox pan-Orthopoxvirus. [DOI] 10.1093/infdis/jiad058
SARS-CoV-2 RdRp uses NDPs as a substrate and is able to incorporate NHC into RNA from diphosphate form molnupiravirArticle Published on 2023-01-312023-07-11 Journal: International journal of biological macromolecules [Category] COVID19(2023년), [키워드] molnupiravir Nucleoside diphosphate RNA dependent RNA polymerase SARS-CoV-2 [DOI] 10.1016/j.ijbiomac.2022.12.112 PMC 바로가기
Characteristics and outcomes of US Veterans at least 65 years of age at high risk of severe SARS-CoV-2 infection with or without receipt of oral antiviral agents ☆Original Article Published on 2023-01-242024-09-05 Journal: The Journal of infection [Category] update2024, [키워드] molnupiravir Nirmatrelvir/ritonavir SARS-COV-2 infection vaccination [DOI] 10.1016/j.jinf.2023.01.018 PMC 바로가기 [Article Type] Original Article
Common variable immunodeficiency with granulomatous‐lymphocytic interstitial lung disease treated with monoclonal antibodies against COVID ‐19: A case reportCase Report Published on 2023-01-232024-09-04 Journal: Clinical Case Reports [Category] 대상포진, [키워드] COVID‐19 CVID GLILD molnupiravir Primary Immunodeficiency Sotrovimab [DOI] 10.1002/ccr3.6776 PMC 바로가기 [Article Type] Case Report
Impact of Early SARS-CoV-2 Antiviral Therapy on Disease ProgressionArticle Published on 2022-12-272023-07-11 Journal: Viruses [Category] COVID19(2023년), [키워드] Antiviral treatment COVID-19 Disease progression molnupiravir monoclonal antibody Nirmatrelvir/ritonavir Remdesivir SARS-CoV-2 vaccination [DOI] 10.3390/v15010071 PMC 바로가기
Why Molnupiravir Fails in Hospitalized PatientsArticle Published on 2022-12-202023-07-10 Journal: mBio [Category] COVID19(2023년), [키워드] antivirals hollow fiber infection model molnupiravir Pharmacodynamics SARS-CoV-2 [DOI] 10.1128/mbio.02916-22 PMC 바로가기
Treatment Options for Patients With Mild-to-Moderate Coronavirus Disease 2019 in KoreaReview Published on 2022-12-122023-07-11 Journal: Journal of Korean medical science [Category] COVID19(2023년), [키워드] antivirals Coronavirus disease 2019 molnupiravir Nirmatrelvir-ritonavir non-hospitalized Remdesivir SARS-CoV-2 [DOI] 10.3346/jkms.2022.37.e352 PMC 바로가기 [Article Type] Review